首页|A genetic insight into vitamin D binding protein and COVID-19
A genetic insight into vitamin D binding protein and COVID-19
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
It's since December 2019 that Corona virus disease (COVID-19) has emerged to be the global issue of concern。 A "pandemic"; this is what WHO has declared about the COVID-19 outbreak on March 3rd， 2020。 Vitamin D and its deficiency have recently been claimed to be one of the potential factors affecting COVID-19 risks and outcomes [1]。 As Selberstein et al。， has recently discussed the effect of vitamin D deficiency， and the role of vitamin D supplementation in COVID-19 patients [2]， I'd believe that vitamin D binding protein (DBP) is maybe also involved。 A closer look on DBP and its action on regulating the circulatory vitamin D levels， its polymorphisms and their impact on COVID-19 prevalence and mortality， will be briefly discussed。
COVID-19DBPGenetic polymorphismVitamin DImmune responseVitamin D deficiency
Alshahawey, Mona
展开 >
Ain Shams Univ, Fac Pharm, Dept Clin Pharm, Cairo, Egypt
NSTL
Elsevier
